Physician

Catherine C Cranford, MD

According to 2025 Medicare claims, Catherine Cranford, MD (NPI: 1639517279) practices allergy/immunology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1205826559; TIN: 561249571) and primary practice location at 28721-8486. Cranford is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Cranford's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 580 traditional Medicare patients, billed 13,099 HCPCS/CPT codes, and received $227,426 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,258 prescription claims across 266 beneficiaries totaling $713,619 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 86 claims. Open Payments data shows 48 records totaling $915. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $14,161 to $713,619. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,576 and ending at $2,361.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$114K$227K2018 Medicare payment: $22,029 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $181,355 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $221,058 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $169,354 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $197,472 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $203,764 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $227,426 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20183161,721$22,029
201979612,383$181,355
202070013,853$221,058
20216199,953$169,354
20225639,845$197,472
202367612,711$203,764
202458013,099$227,426

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$357K$714K2015 Drug cost: $14,161 (USD; Tot_Drug_Cst)2016 Drug cost: $15,699 (USD; Tot_Drug_Cst)2017 Drug cost: $91,220 (USD; Tot_Drug_Cst)2018 Drug cost: $35,360 (USD; Tot_Drug_Cst)2019 Drug cost: $81,562 (USD; Tot_Drug_Cst)2020 Drug cost: $225,372 (USD; Tot_Drug_Cst)2021 Drug cost: $307,599 (USD; Tot_Drug_Cst)2022 Drug cost: $312,852 (USD; Tot_Drug_Cst)2023 Drug cost: $563,507 (USD; Tot_Drug_Cst)2024 Drug cost: $713,619 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201567279$14,161
201669273$15,699
201794454$91,220
201888255$35,360
2019163611$81,562
20202441,205$225,372
20212491,179$307,599
20222141,119$312,852
20232431,273$563,507
20242661,258$713,619

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$73K$146K2019 Medicare payment: $1,113 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $101,395 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $145,578 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $108,523 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $97,264 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $119,509 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R11$1,113
2020N/R79$101,395
2021N/R98$145,578
2022N/R73$108,523
2023N/R89$97,264
2024N/R86$119,509

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more112143$80
95165Professional service for preparation and provision of 1 or more antigens841,895$10
95117Professional service for multiple injections of allergen2901,407$8
95115Professional service for single injection of allergen113429$6
96160Administration and interpretation of patient-focused health risk assessment125162$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
HizentraImmun Glob G(Igg)/Pro/Iga 0-5019532$117,032
CuvitruImmun Glob G(Igg)/Gly/Iga Ov5014384$92,769
NucalaMepolizumab19532$74,200
XolairOmalizumab12336$61,153
Trelegy ElliptaFluticasone/Umeclidin/Vilanter622,460$52,559

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1555Injection, immune globulin (cuvitru), 100 mgNN/R15$60,770
J1559Injection, immune globulin (hizentra), 100 mgNN/R14$56,669
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R28$1,767
K0552Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, eachNN/R29$303

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.48$915GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Catherine C. Cranford, MD?

Tedicare shows public-source Medicare data for Catherine C. Cranford, MD (NPI 1639517279), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Catherine C. Cranford, MD have ACO affiliation data?

Catherine C. Cranford, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Catherine C. Cranford, MD?

Catherine C. Cranford, MD is linked to ALLERGY PARTNERS, PLLC (billing NPI 1205826559) in the available physician profile data.

Does Catherine C. Cranford, MD have Open Payments data?

Catherine C. Cranford, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.